KELLY LEDERMANN: Open Payments
NPI 1942362215 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 74 payments from 16 companies in 2025. Trend: 2023 $2,060 · 2024 $2,579 · 2025 $1,868
Food & beverage: $1,768Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $392 |
| ABBVIE INC. | 15 | $267 |
| Janssen Biotech, Inc. | 6 | $215 |
| PFIZER INC. | 9 | $173 |
| Incyte Corporation | 4 | $107 |
| Regeneron Healthcare Solutions, Inc. | 3 | $105 |
| Amgen Inc. | 5 | $103 |
| Lilly USA, LLC | 4 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Arcutis Biotherapeutics, Inc. | 4 | $85 |
Products named: DUPIXENT, TREMFYA, CIBINQO, RINVOQ, OPZELURA, Otezla, Sotyktu, Zoryve.
Industry payments across NY — which companies pay providers there.
